4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001193125-26-034633
Options or other derivatives
- Chief Executive Officer acquired 1,600,673 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Collard Craig A · Chief Executive Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-30 | Grant or award : show line 1 in the form Restricted Stock Units | +800,337 | 800,337 | D |
| 2026-01-30 | Grant or award : show line 2 in the form Performance Stock Units | +800,336 | 800,336 | D |
Loading xslF345X05/ownership.xml…